Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Pharmacia & Upjohn discloses new antimicrobial agents

April 29, 1997

Matrix Pharmaceutical announces marketing partner for AccuSite in Spain and Portugal

April 28, 1997

VIMRx completes phase I studies for VIMRxyn

April 28, 1997

Mylan Laboratories's Acyclovir receives FDA approval

April 25, 1997

Lilly prepares water-soluble echinocandin antifungal agents

April 25, 1997

Roussel Uclaf claims new cephalosporins

April 25, 1997

Final FDA approval for Faulding's acyclovir injection

April 24, 1997

Sch-56592 in phase II trials for fungal infections

April 24, 1997

Buckminsterfullerene photodynamically inactivates enveloped viruses

April 23, 1997

Roche reveals cephalosporins

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...